Slide 2

ACRO Releases RBQM Summary Report

ACRO’s new RBQM Summary Report highlights the key takeaways from ACRO’s RBQM survey, outlining the current state of RBM & RBQM in the clinical research industry.

Slide Image
Slide 2
ACRO Releases New RBQM Paper

ACRO’s RBQM Working Group published data from the third annual
landscape survey on how RBM & RBQM is being utilized in clinical trials.

Slide Image
Slide 1
ACRO Releases the Good Clinical Podcast

Join us every Tuesday as we take a look at the current state of clinical research and what direction the industry must head in to continue improving trials for patients.

Slide Image


Get ACRO’s newsletter to stay informed about our work and the industry.

    Load More...

    News and Comments

    Press Releases

    ACRO Launches “Good Clinical Podcast”

    October 12, 2023

    WASHINGTON, DC – ACRO is pleased to announce the launch of its “Good Clinical Podcast.” The podcast brings together leaders in clinical…

    Press Releases

    ACRO Announces 2023 Officers and New Member

    March 6, 2023

    WASHINGTON, DC – Washington DC – ACRO is pleased to announce that its Board of Directors has elected Paul Kirchgraber, M.D., Executive…

    Press Releases

    ACRO Expands Decentralized Clinical Trials Toolkit with Release of Change Management Resource

    October 18, 2022

    WASHINGTON, DC – Today, the Association of Clinical Research Organizations (ACRO)’s DCT Working Party releases the latest addition to its DCT Toolkit:…


    ACRO & TransCelerate Issue a Joint Statement on Considerations while Developing Clinical Study Reports (CSRs)

    September 12, 2022

    Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war…

    Press Releases

    ACRO Releases Diversity and Inclusion Principles Statement in Support of More Diverse Clinical Trials

    August 25, 2022

    WASHINGTON, DC – This week, the Association of Clinical Research Organizations (ACRO)’s Diversity and Inclusion in Clinical Trials committee is proud to…


    OPINION: Keep Our Foot on the Gas for Clinical Trial Diversity

    August 8, 2022

    The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…

    US Regulatory Policy

    Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »

    European Advocacy

    ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »

    CRO Forum

    ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »

    Clinical Research Roundtables

    In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »

    Data Protection & Privacy

    ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »

    Join ACRO and Add Your Voice

    We help create a global regulatory and business environment
    where ACRO members succeed

    ACRO Members